LIXTE BIOTECHNOLOGY HOLDINGS (LIXT) 0.8518 +0.08 (+10.88%)
0.8518 +0.08 (+10.88%)
US5393192027 - Common Stock - After market: 0.8183 -0.03 (-3.93%)
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 6.70M | 6.72M | 3.27M | 2.49M | 2.14M | |||
| Interest Expense | -6.78K | -7.95K | 0.00 | 50.00K | 0.00 | |||
| Income Before Taxes | -6.71M | -6.73M | -3.26M | -2.44M | -2.13M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -6.71M | -6.73M | -3.26M | -2.44M | -2.13M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.45 | -0.50 | -0.29 | -0.22 | -0.22 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD